-SEC Filing
Aethlon Medical Announces Investigation Of The Hemopurifier For Use In Organ Transplantation
Research to Confirm the Hemopurifier's Ability to Remove Harmful Viruses and Exosomes From Harvested Organs
SAN DIEGO, June 21, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical